Internal Medicine · Woodland, CA
NPI
1164537858
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
632 W Gibson Rd
Woodland, CA, 95695
Phone (530) 668-2600
Groups this clinician bills Medicare through
Medicare paid, 2024
$219K
3,760 services
Medicare patients, 2024
676
Average age 77
Drug cost, 2024
$1.7M
22,296 prescriptions
Company payments, 2024
$137
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alexander K Chen was code J0897 (injection, denosumab, 1 mg), 1,320 times for 14 patients. In total Alexander K Chen billed 3,760 services in 60 codes, and Medicare paid $219K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-09-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,320 | 14 | $20.61 | $27K |
| 99214 Office E&M - Established | Office | 546 | 332 | $88.53 | $48K |
| 99213 Office E&M - Established | Office | 377 | 245 | $69.44 | $26K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 249 | 249 | $145.70 | $36K |
| G0008 Administration of influenza virus vaccine | Office | 168 | 165 | $33.81 | $5,680 |
| 90653 Vaccine Product | Office | 142 | 142 | $81.24 | $12K |
| 99211 Office E&M - Established | Office | 106 | 59 | $18.53 | $1,964 |
| 83036 Blood Count | Office | 103 | 78 | $9.52 | $981 |
| 90480 Vaccine Administration | Office | 88 | 82 | $45.54 | $4,008 |
| 91320 Vaccine Product | Office | 86 | 81 | $145.72 | $13K |
| 99309 SNF E&M | Office | 62 | 42 | $76.57 | $4,747 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 49 | 41 | $243.00 | $12K |
| 96372 Injection Administration | Office | 42 | 29 | $12.33 | $518 |
| 99309 SNF E&M | Facility | 37 | 28 | $94.38 | $3,492 |
| 99212 Office E&M - Established | Office | 31 | 29 | $39.66 | $1,229 |
By year: 2022 $177K for 2,801 services; 2023 $175K for 2,670 services; 2024 $219K for 3,760 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 103 | 78 | $9.52 | $981 |
| 81003 Clinical Chemistry | 13 | 12 | $2.20 | $28.6 |
Medicare prescription drug claims, 2024
In 2024, the drug Alexander K Chen prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,186 prescriptions and refills. In total Alexander K Chen wrote 22,296 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,186 | 2,559 | 267 | $10K |
| Levothyroxine Sodium Generic | 793 | 1,730 | 163 | $11K |
| Losartan Potassium Generic | 771 | 1,924 | 201 | $8,213 |
| Amlodipine Besylate Generic | 713 | 1,684 | 188 | $4,411 |
| Lisinopril Generic | 682 | 1,577 | 157 | $5,024 |
| Gabapentin Generic | 586 | 969 | 119 | $9,465 |
| Metoprolol Succinate Generic | 532 | 1,305 | 138 | $8,139 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 500 | 500 | 87 | $14K |
| Omeprazole Generic | 478 | 916 | 97 | $5,255 |
| Xarelto Rivaroxaban | 372 | 540 | 57 | $260K |
| Tamsulosin Hcl Generic | 361 | 784 | 85 | $5,012 |
| Simvastatin Generic | 351 | 860 | 85 | $3,006 |
| Furosemide Generic | 322 | 623 | 75 | $1,796 |
| Metformin Hcl Er Metformin Hcl | 285 | 644 | 74 | $3,426 |
| Trazodone Hcl Generic | 283 | 543 | 64 | $3,040 |
Brand drugs: 2,384 claims; generic drugs: 19,805 claims; opioid claims: 1,125.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Alexander K Chen $137 ($137 in general payments such as food, travel and fees) from 1 company. The largest payer was Amgen Inc. with $137.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 1 | $137 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.